Determining costs of health care services for cost-effectiveness analyses: The case of cervical cancer prevention and treatment

L. Jay Helms, Joy Melnikow

Research output: Contribution to journalArticle

34 Citations (Scopus)

Abstract

OBJECTIVES. To estimate costs for the prevention and treatment of cervical cancer based on resource utilization and to compare those costs to published estimates and to local charges and reimbursements. DESIGN. Cost estimates for cervical cancer prevention services were based on clinic staff time, use of specialized equipment and supplies, laboratory costs, and clinic overhead. Cost estimates for cervical cancer treatment were based on HMO expenditures for cervical cancer patients and control patients. These costs were adjusted for stage distribution and survival rates. Published cost estimates were obtained from a systematic review of the medical literature between 1990 and 1996. SETTING. Three family planning clinics (for prevention costs) and a staff-model HMO (for treatment costs). PATIENTS. For treatment costs: 98 cervical cancer patients and 133,058 female control patients, matched by age and chronic disease score. MAIN OUTCOME MEASURES. Estimated costs for prevention and treatment of cervical cancer. Cost-to-charge and cost-to-reimbursement ratios. RESULTS. Costs of cervical cancer prevention and treatment services have been determined using a variety of methods. We found substantial variation in these estimates, even for studies with similar methodologies. Detailed resource-based estimation suggests that prevention costs are generally lower than those previously published in the literature, whereas the costs of cervical cancer treatment are generally higher. CONCLUSIONS. It is practical and desirable to employ resource use-based estimates of medical costs in cost-effectiveness analyses. Failure to do so for cervical cancer may affect policy recommendations by understating the relative benefits of prevention programs.

Original languageEnglish (US)
Pages (from-to)652-661
Number of pages10
JournalMedical Care
Volume37
Issue number7
DOIs
StatePublished - Jul 1999

Fingerprint

health care services
Uterine Cervical Neoplasms
Health Care Costs
Health Services
Cost-Benefit Analysis
cancer
Costs and Cost Analysis
costs
Therapeutics
Health Maintenance Organizations
Family Planning Services
resources
Health Expenditures
staff
Chronic Disease
Survival Rate
family planning

Keywords

  • Cervical cancer
  • Health care costs
  • Prevention

ASJC Scopus subject areas

  • Nursing(all)
  • Public Health, Environmental and Occupational Health
  • Health(social science)
  • Health Professions(all)

Cite this

Determining costs of health care services for cost-effectiveness analyses : The case of cervical cancer prevention and treatment. / Helms, L. Jay; Melnikow, Joy.

In: Medical Care, Vol. 37, No. 7, 07.1999, p. 652-661.

Research output: Contribution to journalArticle

@article{8c8983fc930749e8b955a04720b526a5,
title = "Determining costs of health care services for cost-effectiveness analyses: The case of cervical cancer prevention and treatment",
abstract = "OBJECTIVES. To estimate costs for the prevention and treatment of cervical cancer based on resource utilization and to compare those costs to published estimates and to local charges and reimbursements. DESIGN. Cost estimates for cervical cancer prevention services were based on clinic staff time, use of specialized equipment and supplies, laboratory costs, and clinic overhead. Cost estimates for cervical cancer treatment were based on HMO expenditures for cervical cancer patients and control patients. These costs were adjusted for stage distribution and survival rates. Published cost estimates were obtained from a systematic review of the medical literature between 1990 and 1996. SETTING. Three family planning clinics (for prevention costs) and a staff-model HMO (for treatment costs). PATIENTS. For treatment costs: 98 cervical cancer patients and 133,058 female control patients, matched by age and chronic disease score. MAIN OUTCOME MEASURES. Estimated costs for prevention and treatment of cervical cancer. Cost-to-charge and cost-to-reimbursement ratios. RESULTS. Costs of cervical cancer prevention and treatment services have been determined using a variety of methods. We found substantial variation in these estimates, even for studies with similar methodologies. Detailed resource-based estimation suggests that prevention costs are generally lower than those previously published in the literature, whereas the costs of cervical cancer treatment are generally higher. CONCLUSIONS. It is practical and desirable to employ resource use-based estimates of medical costs in cost-effectiveness analyses. Failure to do so for cervical cancer may affect policy recommendations by understating the relative benefits of prevention programs.",
keywords = "Cervical cancer, Health care costs, Prevention",
author = "Helms, {L. Jay} and Joy Melnikow",
year = "1999",
month = "7",
doi = "10.1097/00005650-199907000-00005",
language = "English (US)",
volume = "37",
pages = "652--661",
journal = "Medical Care",
issn = "0025-7079",
publisher = "Lippincott Williams and Wilkins",
number = "7",

}

TY - JOUR

T1 - Determining costs of health care services for cost-effectiveness analyses

T2 - The case of cervical cancer prevention and treatment

AU - Helms, L. Jay

AU - Melnikow, Joy

PY - 1999/7

Y1 - 1999/7

N2 - OBJECTIVES. To estimate costs for the prevention and treatment of cervical cancer based on resource utilization and to compare those costs to published estimates and to local charges and reimbursements. DESIGN. Cost estimates for cervical cancer prevention services were based on clinic staff time, use of specialized equipment and supplies, laboratory costs, and clinic overhead. Cost estimates for cervical cancer treatment were based on HMO expenditures for cervical cancer patients and control patients. These costs were adjusted for stage distribution and survival rates. Published cost estimates were obtained from a systematic review of the medical literature between 1990 and 1996. SETTING. Three family planning clinics (for prevention costs) and a staff-model HMO (for treatment costs). PATIENTS. For treatment costs: 98 cervical cancer patients and 133,058 female control patients, matched by age and chronic disease score. MAIN OUTCOME MEASURES. Estimated costs for prevention and treatment of cervical cancer. Cost-to-charge and cost-to-reimbursement ratios. RESULTS. Costs of cervical cancer prevention and treatment services have been determined using a variety of methods. We found substantial variation in these estimates, even for studies with similar methodologies. Detailed resource-based estimation suggests that prevention costs are generally lower than those previously published in the literature, whereas the costs of cervical cancer treatment are generally higher. CONCLUSIONS. It is practical and desirable to employ resource use-based estimates of medical costs in cost-effectiveness analyses. Failure to do so for cervical cancer may affect policy recommendations by understating the relative benefits of prevention programs.

AB - OBJECTIVES. To estimate costs for the prevention and treatment of cervical cancer based on resource utilization and to compare those costs to published estimates and to local charges and reimbursements. DESIGN. Cost estimates for cervical cancer prevention services were based on clinic staff time, use of specialized equipment and supplies, laboratory costs, and clinic overhead. Cost estimates for cervical cancer treatment were based on HMO expenditures for cervical cancer patients and control patients. These costs were adjusted for stage distribution and survival rates. Published cost estimates were obtained from a systematic review of the medical literature between 1990 and 1996. SETTING. Three family planning clinics (for prevention costs) and a staff-model HMO (for treatment costs). PATIENTS. For treatment costs: 98 cervical cancer patients and 133,058 female control patients, matched by age and chronic disease score. MAIN OUTCOME MEASURES. Estimated costs for prevention and treatment of cervical cancer. Cost-to-charge and cost-to-reimbursement ratios. RESULTS. Costs of cervical cancer prevention and treatment services have been determined using a variety of methods. We found substantial variation in these estimates, even for studies with similar methodologies. Detailed resource-based estimation suggests that prevention costs are generally lower than those previously published in the literature, whereas the costs of cervical cancer treatment are generally higher. CONCLUSIONS. It is practical and desirable to employ resource use-based estimates of medical costs in cost-effectiveness analyses. Failure to do so for cervical cancer may affect policy recommendations by understating the relative benefits of prevention programs.

KW - Cervical cancer

KW - Health care costs

KW - Prevention

UR - http://www.scopus.com/inward/record.url?scp=0033161669&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0033161669&partnerID=8YFLogxK

U2 - 10.1097/00005650-199907000-00005

DO - 10.1097/00005650-199907000-00005

M3 - Article

C2 - 10424636

AN - SCOPUS:0033161669

VL - 37

SP - 652

EP - 661

JO - Medical Care

JF - Medical Care

SN - 0025-7079

IS - 7

ER -